BACKGROUND: Peptide YY (PYY(3-36)) infused to levels within the physiological range reduces appetite and food intake in humans without nausea. However, PYY(3-36) has previously been shown to cause nausea at higher doses. METHODS: We studied the relationship of PYY(3-36), nausea and food intake in six volunteers, using three different PYY(3-36) preparations infused to achieve supraphysiological PYY plasma levels. RESULTS: Supraphysiological levels of PYY caused nausea in five subjects (P < 0.05). Although PYY(3-36) increased satiety (P < 0.05) and reduced food intake (P < 0.05), no greater enhancement of satiety or inhibition of food intake was observed compared with previous reports. CONCLUSIONS: This study cautions against the use of supraphysiological doses of PYY(3-36) as it may increase nausea with no benefit in food reduction.
BACKGROUND:Peptide YY (PYY(3-36)) infused to levels within the physiological range reduces appetite and food intake in humans without nausea. However, PYY(3-36) has previously been shown to cause nausea at higher doses. METHODS: We studied the relationship of PYY(3-36), nausea and food intake in six volunteers, using three different PYY(3-36) preparations infused to achieve supraphysiological PYY plasma levels. RESULTS: Supraphysiological levels of PYY caused nausea in five subjects (P < 0.05). Although PYY(3-36) increased satiety (P < 0.05) and reduced food intake (P < 0.05), no greater enhancement of satiety or inhibition of food intake was observed compared with previous reports. CONCLUSIONS: This study cautions against the use of supraphysiological doses of PYY(3-36) as it may increase nausea with no benefit in food reduction.
Authors: Gordon W Moran; Fiona C Leslie; Scott E Levison; J Worthington; John T McLaughlin Journal: Therap Adv Gastroenterol Date: 2008-07 Impact factor: 4.409
Authors: Shamina M Rangwala; Katharine D'Aquino; Yue-Mei Zhang; Lindsay Bader; Wilson Edwards; Songmao Zheng; Annette Eckardt; Ann Lacombe; Rebecca Pick; Veronica Moreno; Lijuan Kang; Wenying Jian; Eric Arnoult; Martin Case; Celia Jenkinson; Ellen Chi; Ronald V Swanson; Paul Kievit; Kevin Grove; Mark Macielag; Mark D Erion; Ranabir SinhaRoy; James N Leonard Journal: Cell Metab Date: 2019-02-14 Impact factor: 27.287
Authors: Kerstin Stemmer; Timo D Müller; Richard D DiMarchi; Paul T Pfluger; Matthias H Tschöp Journal: J Clin Invest Date: 2019-08-05 Impact factor: 14.808
Authors: Jason C G Halford; Emma J Boyland; John E Blundell; Tim C Kirkham; Joanne A Harrold Journal: Nat Rev Endocrinol Date: 2010-03-16 Impact factor: 43.330
Authors: Benjamin C T Field; Alison M Wren; Veronique Peters; Kevin C R Baynes; Niamh M Martin; Michael Patterson; Sara Alsaraf; Vian Amber; Katie Wynne; Mohammad A Ghatei; Stephen R Bloom Journal: Diabetes Date: 2010-03-31 Impact factor: 9.461